Search research articles
Contact Us
Filters
Showing results (31-40 of 90) with videos related to
Page
of 9
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
February 8, 2018
Functional Implications of Cross-Linked Actin Networks in Trabecular Meshwork Cells
Laura Duffy, Steven O'Reilly
Current Rheumatology Reports
|
June 21, 2020
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
Monique Hinchcliff, Steven O'Reilly
Current Opinion in Rheumatology
|
September 21, 2018
Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma: advances and opportunities for therapy
Max Brown, Steven O'Reilly
International Journal of Molecular Sciences
|
September 13, 2016
A MicroRNA that Regulates TLR-Mediated Fibrosis
Laura Duffy, Steven O'Reilly
Rheumatology (Oxford, England)
|
January 9, 2018
A therapy for systemic sclerosis: STAT!
John Henderson, Steven O'Reilly
Trends in Endocrinology and Metabolism: TEM
|
May 24, 2021
The emerging role of metabolism in fibrosis
John Henderson, Steven O'Reilly
European Journal of Cell Biology
|
June 28, 2016
DNA methylation in fibrosis
Christopher Dowson, Steven O'Reilly
Journal of Dermatological Science
|
January 18, 2025
Aberrant fumarate metabolism links interferon release in diffuse systemic sclerosis
Thomas Steadman, Steven O'Reilly
Trends in Molecular Medicine
|
July 14, 2024
Striking senescence with sodium transporter inhibition
Bettina Schock, Steven O'Reilly
Arthritis Research & Therapy
|
September 20, 2017
Inflammasome lights up in systemic sclerosis
John Henderson, Steven O'Reilly
Page
of 9
Search research articles
Search
Showing results (31-40 of 90) with videos related to
Sort By:
Page
of 9
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
February 8, 2018
Functional Implications of Cross-Linked Actin Networks in Trabecular Meshwork Cells
Laura Duffy, Steven O'Reilly
Current Rheumatology Reports
|
June 21, 2020
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
Monique Hinchcliff, Steven O'Reilly
Current Opinion in Rheumatology
|
September 21, 2018
Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma: advances and opportunities for therapy
Max Brown, Steven O'Reilly
International Journal of Molecular Sciences
|
September 13, 2016
A MicroRNA that Regulates TLR-Mediated Fibrosis
Laura Duffy, Steven O'Reilly
Rheumatology (Oxford, England)
|
January 9, 2018
A therapy for systemic sclerosis: STAT!
John Henderson, Steven O'Reilly
Trends in Endocrinology and Metabolism: TEM
|
May 24, 2021
The emerging role of metabolism in fibrosis
John Henderson, Steven O'Reilly
European Journal of Cell Biology
|
June 28, 2016
DNA methylation in fibrosis
Christopher Dowson, Steven O'Reilly
Journal of Dermatological Science
|
January 18, 2025
Aberrant fumarate metabolism links interferon release in diffuse systemic sclerosis
Thomas Steadman, Steven O'Reilly
Trends in Molecular Medicine
|
July 14, 2024
Striking senescence with sodium transporter inhibition
Bettina Schock, Steven O'Reilly
Arthritis Research & Therapy
|
September 20, 2017
Inflammasome lights up in systemic sclerosis
John Henderson, Steven O'Reilly
Page
of 9